Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Low-dose Hydroxychloroquine and Bromhexine: a Novel Regimen for COVID-19 Prophylaxis in Healthcare Professionals (ELEVATE Trial)

NCT04340349 is registered in ClinicalTrials.gov with Instituto Nacional de Rehabilitacion as lead sponsor.

NCT NCT04340349
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04340349 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Low-dose Hydroxychloroquine and Bromhexine: a Novel Regimen for COVID-19 Prophylaxis in Healthcare Professionals (ELEVATE Trial)
Lead sponsor
Instituto Nacional de Rehabilitacion
Phase
Phase 1
Overall status
Unknown status
Start date
February 1, 2021
Completion date
June 30, 2021
Enrollment
214 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

antimalarials, antirheumatic agents, enzyme inhibitors, hydroxychloroquine